Trenbolone is considered to be one of the best steroids both in terms of mass building and in the preparation phase for a competition. It is a strongly anabolic and strongly androgenic agent. In a word, a top shelf agent for advanced players.
Tren is several times more anabolic and androgenic than Testosterone. However, when using Paraboln, there is no aromatization as when using Testosterone.
In addition, it increases IGF-1, which makes it one of the most effective steroids. Its drawback may be its kidney / liver toxicity and a very common cough during its use.
The list of positive effects of Tren use is longer than the negative ones. The positives include, among others fast and lasting increase in strength and muscle mass, amazing pump, increase in endurance, fat reduction, no water retention during use, excellent hardness and muscle definition.
The negative effects are primarily increased aggression, headaches, nosebleeds, oily skin, acne, prostate enlargement, and strong blocking of the endocrine system.
Parabolan is most often combined with “dry” agents such as Testosterone Propionat, Winstrol, Oxandrolone, Boldenone, Masteron, Primobolan and in cycles with HGH. It works equally well in combination with the popular Metanabol.
Those who want an extreme increase in strength also combine it with Oxymetholone or Halotestin. It should not be combined with Nandrolone because progesterone gynecomastia may occur.
The acetate version is usually taken at a dose of 50-100 mg daily or every two days, the hexa version in similar doses but every 2-4 days due to the longer half-life.
The dose should be adjusted according to your advancement and the concentration you have (currently there are several concentrations for both the acetate and hexa versions).
The period of use is usually 4-8 weeks. The train is intended only for advanced players – amateurs / beginners should not use it.
Parabolan strongly blocks the endocrine system, so PCT should be taken into account at the end of the cycle. The standard is HCG, Clomid, Tamoxifen.